QSAR Classification Models for Predicting the Activity of Inhibitors of Beta-Secretase (BACE1) Associated with Alzheimer’s Disease

[1]  M. L. de Ceballos,et al.  Indazolylketones as new multitarget cannabinoid drugs. , 2019, European journal of medicinal chemistry.

[2]  R. Tanzi,et al.  BACE1 Regulates Proliferation and Neuronal Differentiation of Newborn Cells in the Adult Hippocampus in Mice , 2018, eNeuro.

[3]  T. Dinis,et al.  Highlights in BACE1 Inhibitors for Alzheimer's Disease Treatment , 2018, Front. Chem..

[4]  B. Strooper,et al.  Modulation of γ- and β-Secretases as Early Prevention Against Alzheimer’s Disease , 2018, Biological Psychiatry.

[5]  Maria Vanina Martinez,et al.  Hybridizing Feature Selection and Feature Learning Approaches in QSAR Modeling for Drug Discovery , 2017, Scientific Reports.

[6]  Fiorella Cravero,et al.  Feature Learning applied to the Estimation of Tensile Strength at Break in Polymeric Material Design. , 2016, Journal of integrative bioinformatics.

[7]  M. Prince,et al.  World Alzheimer report 2016: improving healthcare for people living with dementia: coverage, quality and costs now and in the future , 2016 .

[8]  Danishuddin,et al.  Descriptors and their selection methods in QSAR analysis: paradigm for drug design. , 2016, Drug discovery today.

[9]  Ignacio Ponzoni,et al.  Visual analytics in cheminformatics: user-supervised descriptor selection for QSAR methods , 2015, Journal of Cheminformatics.

[10]  S. Basu,et al.  Encompassing receptor flexibility in virtual screening using ensemble docking-based hybrid QSAR: discovery of novel phytochemicals for BACE1 inhibition. , 2014, Molecular bioSystems.

[11]  Sukriti Goyal,et al.  Novel Fragment‐Based QSAR Modeling and Combinatorial Design of Pyrazole‐Derived CRK3 Inhibitors as Potent Antileishmanials , 2014, Chemical biology & drug design.

[12]  C. Willett,et al.  Building on a solid foundation: SAR and QSAR as a fundamental strategy to reduce animal testing$ , 2014, SAR and QSAR in environmental research.

[13]  Scott Boyer,et al.  Choosing Feature Selection and Learning Algorithms in QSAR , 2014, J. Chem. Inf. Model..

[14]  Marc C. Nicklaus,et al.  QSAR Modeling of Imbalanced High-Throughput Screening Data in PubChem , 2014, J. Chem. Inf. Model..

[15]  Guixue Wang,et al.  Comprehensive 3D-QSAR and binding mode of BACE-1 inhibitors using R-group search and molecular docking. , 2013, Journal of molecular graphics & modelling.

[16]  M. Shahlaei.  Descriptor selection methods in quantitative structure-activity relationship studies: a review study. , 2013, Chemical reviews.

[17]  Roberto Todeschini,et al.  Quantitative Structure − Activity Relationship Models for Ready Biodegradability of Chemicals , 2013 .

[18]  Anthony F. Nastase,et al.  Simple Structure-Based Approach for Predicting the Activity of Inhibitors of Beta-Secretase (BACE1) Associated with Alzheimer's Disease , 2012, J. Chem. Inf. Model..

[19]  John P. Overington,et al.  ChEMBL: a large-scale bioactivity database for drug discovery , 2011, Nucleic Acids Res..

[20]  Katrin Stierand,et al.  Consistent two-dimensional visualization of protein-ligand complex series , 2011, J. Cheminformatics.

[21]  Katrin Stierand,et al.  From Structure Diagrams to Visual Chemical Patterns , 2010, J. Chem. Inf. Model..

[22]  Nanda Ghoshal,et al.  Rationalizing fragment based drug discovery for BACE1: insights from FB-QSAR, FB-QSSR, multi objective (MO-QSPR) and MIF studies , 2010, J. Comput. Aided Mol. Des..

[23]  M. Citron,et al.  Alzheimer's disease: strategies for disease modification , 2010, Nature Reviews Drug Discovery.

[24]  Rongxi Yang,et al.  The enhancement of amyloid precursor protein and beta-site amyloid cleavage enzyme 1 interaction: amyloid-beta production with aging. , 2010, International journal of molecular medicine.

[25]  B. Strooper,et al.  The secretases: enzymes with therapeutic potential in Alzheimer disease , 2010, Nature Reviews Neurology.

[26]  C. G. Mohan,et al.  Comparative molecular field analysis and comparative molecular similarity indices analysis of hydroxyethylamine derivatives as selective human BACE-1 inhibitor , 2010, Molecular Diversity.

[27]  Ignacio Ponzoni,et al.  Multi‐Objective Feature Selection in QSAR Using a Machine Learning Approach , 2009 .

[28]  Steve Iliffe,et al.  Alzheimer’s disease , 2009, BMJ : British Medical Journal.

[29]  Hugo Kubinyi,et al.  QSAR in Drug Design , 2008 .

[30]  R. Vassar,et al.  BACE1 structure and function in health and Alzheimer's disease. , 2008, Current Alzheimer research.

[31]  Ignacio Ponzoni,et al.  A Wrapper-Based Feature Selection Method for ADMET Prediction Using Evolutionary Computing , 2008, EvoBIO.

[32]  Gerta Rücker,et al.  y-Randomization and Its Variants in QSPR/QSAR , 2007, J. Chem. Inf. Model..

[33]  T. Guo,et al.  Development of BACE1 inhibitors for Alzheimer's disease. , 2006, Current medicinal chemistry.

[34]  Qing Zhang,et al.  The Molecular Biology Toolkit (MBT): a modular platform for developing molecular visualization applications , 2005, BMC Bioinformatics.

[35]  Leo Breiman,et al.  Random Forests , 2001, Machine Learning.

[36]  D. Selkoe,et al.  Translating cell biology into therapeutic advances in Alzheimer's disease , 1999, Nature.

[37]  Ron Kohavi,et al.  Wrappers for Feature Subset Selection , 1997, Artif. Intell..

[38]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .

[39]  G. Klebe,et al.  Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. , 1994, Journal of medicinal chemistry.

[40]  W. L. Jorgensen,et al.  The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin. , 1988, Journal of the American Chemical Society.

[41]  J. Topliss,et al.  Chance factors in studies of quantitative structure-activity relationships. , 1979, Journal of medicinal chemistry.

[42]  J. Topliss,et al.  Chance correlations in structure-activity studies using multiple regression analysis , 1972 .

[43]  S. Rigatti.  Random Forest. , 2017, Journal of insurance medicine.

[44]  KrishnaKant Gupta,et al.  Qsar Studies on Gallic Acid Derivatives and Molecular Docking Studies of Bace1 Enzyme - A Potent Target of Alzheimer Disease. , 2014 .

[45]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[46]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[47]  J. Topliss,et al.  Change correlations in structure-activity studies using multiple regression analysis. , 1972, Journal of Medicinal Chemistry.